Catalyst Wire Dossier Catalyst Wire Dossier

Morning After

LEVONORGESTREL · Rapha Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Morning After, covering 2018-09-18 to 2018-09-18. Get the full timeline:

Most recent: FDA Approved: MORNING AFTER — Original Application (Rapha Pharmaceuticals, Inc.)

See pricing